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Available online 13 February 2016Almost all epithelial tumours contain cancer stem-like cells, which possess a unique property of self-renewal and
differentiation. In oral cancer, several biomarkers including cell surface molecules have been exploited for the
identiﬁcation of this highly tumorigenic population. Implicit is the role of CD44 in deﬁning CSCs but CD24 is
not well-explored. Here we show that CD44highCD24low cells isolated from the oral cancer cell lines, not only ex-
press stem cell related genes but also exhibit Epithelial-to-Mesenchymal transition (EMT) characteristics. This
CD44highCD24low population gives rise to all other cell types upon differentiation. Typical Cancer Stem Cell
(CSC) phenotypes like increased colony formation, sphere forming ability,migration and invasionwere also con-
ﬁrmed in CD44highCD24low cells. Drug transporters were found to be over-expressed in CD44highCD24low sub-
population thereby contributing to elevated chemo-resistance. To validate our ﬁndings in-vivo, we determined
the relative expression of CD44 and CD24 in clinical samples of OSCC patients. CD44 expression was consistently
highwhereas CD24 showed signiﬁcantly lower expression in tumour tissues. Further, the gene expression proﬁle
of the CSC and non-CSCpopulation unravels themolecular pathwayswhichmay contribute to stemness.We con-
clude that CD44highCD24low represents cancer stem-like cells in Oral Squamous Cell Carcinoma.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Oral Squamous Cell Carcinoma (OSCC) is one of the most prevalent
subtype of Head and Neck Cancers worldwide afﬂicting N300,000 peo-
ple annually, with ~150,000 deaths. (http://globocan.iarc.fr/Pages/
fact_sheets_population.aspx) (Felthaus et al., 2011). The 5-year survival
rate for the disease has not improved through decades, despite ad-
vances in treatment modalities that predominantly include surgery
and sometimes chemo-radiotherapy (Davis et al., 2010; Chikamatsu
et al., 2012). The major cause of failure to cure OSCC includes resistance
to therapy, recurrence and metastasis, both local and distant (Mitra
et al., 2011).Most of this phenomenon is attributed to the diverse archi-
tecture of this tumour that consists of functionally heterogeneous line-
ages of cancer cells (Kreso and Dick, 2014; Sayed et al., 2011). In this
context, role of Cancer Stem Cells, a self-renewing subpopulation ofcer Stem Cells; EMT, Epithelial
arcinoma; SP, Side Population;
ntre and Research Institute,
ry).
. This is an open access article undertumour cells that sustain the long-term clonal growth of cancers, is ev-
ident (Magee et al., 2012; Clarke et al., 2006). The CSCs escape chemo-
therapy and are responsible for the recurrence of even more
aggressive tumours (Valiyaveedan et al., 2015; Chen, 2009). This hy-
pothesis has gained support in a variety of tumours in addition to cul-
tured cancer cell lines that are shown to harbour CSC-like cells
(Chaffer et al., 2013; Yeung et al., 2010; Iacopino et al., 2014). It is advan-
tageous to use malignant cell lines as they are not contaminated with
normal stem cells or cancer associated stroma and available in large
numbers. Hence cell lines serve as a promising model for exploring
the biology of CSCs in multiple cancers.
Deﬁning CSC with speciﬁc markers has become difﬁcult due to its
frequent phenotypic transitions (Clevers, 2011; Shah et al., 2014). Vari-
ousmarkers independently or in combination have been investigated to
study CSCs from various tumours. These include a series of CSC-entity
specifying molecules based on surface marker expression, drug trans-
porters, enzymatic activity, signalling pathways and so on (Routray
and Mohanty, 2014; Major et al., 2013). A couple of studies evaluated
ALdh1 activity as a functional marker for isolation of CSC-like cells in
OSCC (Zou et al., 2012). It was also found to be a relevant CSC marker
in closely related Esophageal SCC along with Bmi1 and Nanog (Hwang
et al., 2014). The “Side Population” analysis was equally effective inthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Yanamoto et al., 2011; Golebiewska et al., 2011). Also, CSCs could be
simply enriched by growing the cancer cells in serum free media
under non-adherent conditions (Chiou et al., 2008). Drug treatment at
intermittent and incremental doses has also been shown to successfully
expand the CSC population (Xu et al., 2015). In addition, activation of
the EMT programme has increasingly been shown to generate CSCs
(Ansieau, 2013). Nonetheless, the utility of surface markers, remained
the most popular of all isolation and characterization strategies.
Prince et al. have proposed CD44+ as the tumour-initiating stem cell
in Head and Neck Cancers that could re-establish the original tumour
heterogeneity (Prince et al., 2007). Besides, other markers like
CD29,CD133, CD24, CD166, and EpCAM in different types of cancers
are also used (Keysar and Jimeno, 2010; Zhang et al., 2009; Hurt et al.,
2008). CD24, a small membrane glycoprotein is of considerable impor-
tance in breast cancer and has recently emerged as amajor determinant
of stemness in various cancer (Sheridan et al., 2006; Jaggupilli and
Elkord, 2012). Although evidences in breast cancer ﬁrmly established
CD44highCD24low cells to be stem-like, studies in HNSCC have not been
conclusive. Here we revisit the prospects of CD44 and CD24 in deﬁning
the Cancer Stem Cell markers of OSCC.
In the present study, we have used a set of OSCC cell lines and
isolated the putative stem cell fraction (CD44highCD24low) along with
CD44highCD24high and CD44lowCD24high (non-stem) sub-populations.
These populations were subjected to various molecular and cellular as-
says to determine whether CD24 has any relevant contribution in the
context of CD44high population towards deﬁning CSC marker. We have




Human OSCC cell lines, UPCI: SCC131, UPCI: SCC084 and UPCI:
SCC036 were purchased from University of Pittsburg, USA (Table S5)
(White et al., 2007). These were cultured in DMEM medium supple-
mentedwith 10% foetal calf serum, 1% Pen Strep and 0.006%Gentamicin
(Life Technologies, Thermo Fisher Scientiﬁc Inc., MA USA). SCC25 was
obtained from American Type Culture Collection and cultured in
DMEM-F12 supplemented with 10% foetal bovine serum (FBS) and
400 ng/ml Hydrocortisone at 37 °C in the presence of 5% CO2.
2.2. MACS and ﬂow cytometry
Magnetic Assisted Cell Sorting was used for the sequential separa-
tion of CD24low followed by CD44high population. The detailed protocol
is provided in Supplementary material. The MACS sorted cell popula-
tions were tested for percentage puriﬁcation using ﬂow cytometry.
About 1 × 106 cells were re-suspended in PBS containing 1% FBS and
0.02% sodium azide and double stained with CD44-PE and CD24-FITC
(BD Pharmingen, San Jose, CA). Cytometry was performed on the BD
LSRFortessa and the data was analysed using BD FACSDiva 6.2 software.
Unstained cells were used to set up the size gate and avoid debris and
clumps. Isotype controls were kept to eliminate non-speciﬁc staining.
For differentiation assay, the CD44highCD24low and CD44lowCD24high
cells isolated from SCC25 were followed for 3 weeks and subjected to
FACS analysis at every week. Unsorted SCC25 were kept as control to
normalize the staining intensity of CD44 and CD24. SCC25 was treated
with 5-FU for 72 h and CD44/CD24 status was assessed for the enrich-
ment of stem-like population upon drug exposure.
2.3. Real time PCR analysis
Total RNA was extracted from the sorted populations using Trizol
Reagent (Invitrogen, Carlsbad, CA) and reverse transcribed to cDNAusing Verso cDNA synthesis kit (Thermo Fisher Scientiﬁc Inc., MD).
Real time PCR was carried out using start universal SYBR Green master
mix (Roche, Basel, Switzerland) on the 7500 Fast Real Time PCR system
(Applied Biosystems, Foster City, CA). Data were normalized with β-
actin. The list of primers and its sequence are given in Supplementary
File S1.
2.4. Western blot
Cells were lysed in NP-40 lysis buffer (Invitrogen, Carlsbad, CA)
supplemented with 1× protease inhibitor cocktail. Clear cell lysates
were measured with Bradford reagent (Sigma-Aldrich, St. Louis, MO).
Equivalent amounts of proteins were separated using SDS-PAGE (8%-
10%), transferred on to PVDF membrane (Millipore, Billerica,) and
immunoblotted with primary antibodies; polyclonal E-cadherin,
Involucrin, CD44, CD24 (Santa Cruz Biotechnology, CA, USA), polyclonal
Oct4, Nanog and Sox2 (Abcam, Cambridge, UK), polyclonal C-myc (Cell
Signalling Technology, Beverly, MA, USA) followed by HRP-conjugated
secondary antibody (Sigma). Bands were visualized using enhanced
chemiluminescence (Thermo Scientiﬁc, Rockford, IL, USA).
2.5. Immunoﬂuorescence
The sorted populations of SCC25were stained with EMTmarkers for
confocal microscopy. The Protocol is given in supplementary in details.
2.6. Sphere forming assay
MACS sorted cell populations were cultured overnight to eliminate
dead cells. Next day, 5000 cells/ml per well of low adherent 6-well
plate were plated in DMEM-F-12 serum free media reconstituted with
1% B27 supplement, 20 ng/ml of Epidermal Growth factor and
20 ng/ml of Basic Fibroblast Growth Factor (Invitrogen). Medium was
added every 2–3 days. Formation of sphere-like structures was visible
at 4–7 days and the photographs of comparable groups were captured
under phase-contrast microscope (Leica CTR4000) at 20× magniﬁca-
tion at 7–14 days. All experiments were done in triplicate.
2.7. Clonogeneic assay
In brief, 1000 cells were seeded on 6 cm dishes and cultured for
7–10 days with medium change every 2–3 days. The colonies were
stained with 0.2% methylene blue for 30 min, washed with PBS to re-
move the extra stain and images were taken. Colonies for three inde-
pendent experiments were counted.
2.8. Monolayer wound healing assay
Different populations of UPCI: SCC131 cell lines were plated at a
density of 1 million cells per well of 6-well plate and allowed to form
a conﬂuent monolayer. A scratch was then made with a thin edge of a
200microtip. Photographswere taken under phase contrastmicroscope
(Olympus 1× 51, camera Jenoptik) at 0 h and after 16–18 h at 10×mag-
niﬁcation. The distance wasmeasured at both the time points, to assess
the migration of cells from the wounded regions. Percent distance mi-
grated were calculated for three independent experiments.
2.9. Matrigel invasion assay
The upper chamber of theMatrigel coated trans-well cell culture in-
serts (BD Biosciences, SanDiego, CA)were seededwith cells at a density
of 0.5 × 106 per well in serum free DMEM. The lower chamber was lay-
eredwith 0.75ml of DMEMwith 10% FBS to serve as a chemo-attractant.
After incubating for 36–48 h, the cells on both the upper and the under-
side of the tranwell inserts were ﬁxed with 3.7% formaldehyde,
permeabilised with methanol and stained with Giemsa (sigma).The
407S. Ghuwalewala et al. / Stem Cell Research 16 (2016) 405–417cells in the upper chamber were removedwith the cotton swab and the
invaded cells on the underside were photographed. Images were ac-
quired using bright ﬁeld microscope (Leica DM3000, Germany) at 10×
magniﬁcation. Three independent ﬁelds were analysed using ImageJ
software. The percentage of cells that invaded through matrigel matrix
was calculated.
2.10. Hoechst dye exclusion assay
The CD44highCD24low and CD44lowCD24high cell populations of UPCI:
SCC131 were resuspended in DMEM medium containing 2% FCS. Five
micrograms of Hoescht 33342 dye (Invitrogen) was added per 106
cells/ml and incubated at 37 °C in dark with intermittent shaking for
90 min. ABC transporter inhibitor, Verapimil (50 μM, Sigma) was used
to block Hoechst efﬂux to set the “Hoechst low” gate. Stained cells
were washed and resuspended in ice-cold PBS containing 2 mg/ml of
Propidium Iodide. Flow cytometry was performed on BD LSRFortessaFig. 1. Isolation of the putative CSC population (CD44highCD24low) using MACS and characte
separation. (B) Each of the enriched cell population of SCC25 cell line was analysed by ﬂow
(MFI) values of CD44 (PE) and CD24 (FITC) are given. Image is representative of 3 independen
CD24 in the stem and the non-stem population of SCC25 cells subjected to FACS analysis ever
of SCC25 using speciﬁc primers (Supplementary File S1). Relative expression values wer
independent experiments. (* denotes p-value b 0.05, ** means p-value b 0.01, *** means p-val(Becton-Dickinson) with UV excitation of 355 nm and the emissions
were captured at 450/50 nm (Hoechst Blue) and 675/50 nm (Hoechst
Red). Gating strategy ensured analysis of only live (PI excluded) and sin-
gle (doublets excluded) cells. From the remaining cells, the least ﬂuo-
rescent population was termed “Side Population” and the percentage
was determined.2.11. Immunohistochemistry
Matched oral tumour (n = 10) and normal (n = 10) tissues along
with 15 dysplastic tissues were obtained from the hospital section,
Chittaranjan National Cancer Institute (CNCI), Kolkata, India. Prior to
sample collection, written informed consent was taken from each indi-
vidual and approved by the Research Ethics Committee of CNCI. The
pathological history of the tumours is provided in Supplementary File
S2. CD44 and CD24 were stained according to the standard protocol.rization of their stemness properties. (A) Flowchart of magnetic bead based sequential
cytometry and the histograms indicated by colour codes. Mean ﬂuorescence intensity
t experiments and presented graphically with mean ± SD. (C) Relative MFI of CD44 and
y week. (D) qRT-PCR quantiﬁcation of stem cell related genes in various sub population
e normalized to those of 18srRNA or β-actin. Data shown is average ± SD for three
ue b 0.001).
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tary material.
2.12. Microarray
Total RNA was extracted from the different fractions of SCC25 using
Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany) using manufacturer's
protocol. From the isolated RNA themRNAwas converted to biotinylated
cRNAs and hybridized on Illumina HT12 V4.0 bead chip whole genome
array (Illumina, San Diego, CA). The Illumina bioarrays were read in an
Illumina iScan Reader (Illumina) and the primary intensity data were
obtained in standard ﬁle format, using Genome Studio software. Raw
data were pre-processed in R bioconductor lumi package (https://www.
bioconductor.org/packages/release/bioc/html/lumi.html). The robust
spline method was used for normalization. Using Benjamini and
Hochberg method, the p-values were corrected for multiple testing.
Genes with FC N 1.5 or FC b 1.5 were considered to be differentially
expressed between different samples. These were subjected to Ingenuity
Pathway Analysis (IPA; https://analysis.ingenuity.com).
2.13. Statistical analysis
For IHC, p-value was calculated using Mann–Whitney's U Test
between median expression values. Survival curve was plotted using
R package with signiﬁcance calculated as Log Rank Test between
two curves. Oncomine 4.4 research edition database (http://www.
oncomine.org/resource/login.html) was used for the analysis. An inde-
pendent two-tailed Student's t test was performed to determine the sig-
niﬁcance of difference between two experiments.
3. Results
3.1. Isolation and characterization of cancer stem-like cells from Oral
Squamous Cell Carcinoma cell lines
A number of reports suggest that cultured human cancer cell lines
contain various cellular subpopulations including CSCs that can be eas-
ily puriﬁed for different molecular analyses (Singh et al., 2003). In the
present study, we subjected a number of oral cancer cell lines such as
SCC25, UPCI-SCC131, UPCI-SCC084 to the isolation of CSC-like cell
population based on CD44 and CD24 markers using Magnetic Assisted
Cell Sorting. Accordingly, we identiﬁed three subpopulations
CD44highCD24low, CD44lowCD24high, and CD44highCD24high from these
cell lines (Fig. 1A). The purity of these cell types was conﬁrmed by
ﬂow cytometry in both SCC25 (Fig. 1B) and UPCI: SCC131 (Fig. S1A).
Each parental cell line showed strong CD44 expression; hence the
puriﬁed CD44high population was quite enriched whereas CD24 fold re-
duction was optimum (Fig. 1B, S1B). The sorted subpopulations were
relatively enriched fractions and not absolutely pure. The different phe-
notypic cell types were studied within 4–5 days of isolation since they
are known to change their characteristic properties to maintain equilib-
rium proportions of various subpopulations in adherent culture (Gupta
et al., 2011). This was evident from the dynamic change in CD44 and
CD24 proﬁle upon prolonged culture that demonstrates the ability of
CD44highCD24low cells to spontaneously propagate all other cell types
(Fig. 1C). No such change was observed in CD44lowCD24high cells
(Fig. 1C). Nevertheless, only the freshly isolated CD44highCD24low cells
were compared with the CD24high cells in the subsequent experiments.
Real Time PCR analysis showed signiﬁcant up-regulation of variousFig. 2. Expression of Intracellular stem cell and EMTmarkers in CD44highCD24low cells. (A) Repr
myc, Involucrin and E-cadherin in the isolated populations of SCC25, UPCI: SCC131 and UPCI: SC
microscopyof E-cadherin (green) andVimentin (red) counterstainedwithDAPI (blue) in SCC25
(C) Quantiﬁcation of the E-cadherin to Vimentin ratio in each cell types with p-value indicated
mesenchymal group compared with the epithelial group of NCI-60 cell lines. DAPI: 4′,6-diamidstem cell markers like Sox2, Bmi1, C-myc in the CD44highCD24low popu-
lation, although Klf4 expression was not statistically signiﬁcant
(Fig. 1D). We also checked Aldh1 expression at mRNA level and found
it to be higher in CD44highCD24low population emphasizing enrichment
of CSC population (Fig. 1D, S1C). In addition, EMT drivers like ZEB1, ATP
binding Casette (ABC) transporters like ABCG2 and metastasis marker
MMP9 were also remarkably higher in the CD44highCD24low compared
with the CD44lowCD24high cell populations. However, expression of
Ki67, a proliferation marker was not signiﬁcantly up-regulated in
CD44highCD24low fraction (Fig. 1D). These results suggest that
CD44highCD24low subpopulation in these cell lines probably possess
the CSC-like property.
3.2. Acquisition of stemness and EMT phenotype in
CD44highCD24low population
We next investigated the expression of well-known stem-related
markers such as Oct4, Nanog, Sox2, C-myc at the protein level. Western
blot analysis showed signiﬁcantly higher expression of these genes
alongwith depletion of differentiationmarker Involucrin in the isolated
CD44highCD24low population of all the cell lines compared with the
CD44low CD24high ones (Fig. 2A, S1D). Moreover, we observed loss of
E-cadherin, perhaps indicating EMT in concordance with increased
stemness (Fig. 2A). Confocal microscopy also showed that E-cadherin
to Vimentin ratio was signiﬁcantly lowered in CD44highCD24low stem
cell population in comparison to the CD44low CD24high non-stem cell
counterparts substantiating the fact that CSC-like property coexists
with EMT phenomenon (Fig. 2B, 2C).We also extrapolated our observa-
tion in Gene expression data sets of NCI-60 cell lines obtained fromgene
array analysis GC34162 at the developmental therapeutics programme
of the NCI; http://dtp.nci.nih.gov (Scherf et al., 2000) (see supplementa-
ry methods). Differential expression of CD44 and CD24 were deter-
mined between epithelial and mesenchymal group of NCI-60 cell lines
that were previously categorized on the basis of E-Cadherin/Vimentin
expression ratio (Park et al., 2008). Interestingly CD44 was signiﬁcantly
higher and CD24 signiﬁcantly lower in the mesenchymal set compared
to the epithelial cell lines (Fig. 2D). These results conﬁrmed that the
CD44highCD24low population exhibits enhanced stem cell characteristics
in conjunction with EMT.
3.3. Self-renewal, migratory and invasive properties of
CD44highCD24low population
We assessed the stem like property of CD44highCD24low cell type by
their intrinsic sphere-forming ability and indeed found the spheres to
be greater in size and number than their non-stem cell counterparts
(CD44lowCD24high) in various cell lines (Fig. 3A, S2A). UPCI: SCC131
cell line was further explored to study the characteristics of the CD44-
highCD24low cell type. Colony forming ability of this population was
higher indicative of their clonogenic potential (Fig. 3B, C). Also
their morphology appeared to be mesenchymal-like, showing
enhanced cellular spreading which comprise the initial steps of
EMT process (Fig. 3D). Moreover, these cancer stem-like cells formed
soft-agar colonies indicating anchorage independent growth ability
of these cells (Fig. S2B). However, the proliferation rate of this
subpopulation was not signiﬁcantly different from the other popula-
tion (Fig. S2C).
Wound healing assay was performed on all the isolated populations
of UPCI: SCC131 cell lines to assess the motility of these cell types.esentative western blot images of CD44, CD24 and relative levels of Oct-4, Nanog, Sox2,C-
C084 cell lines. Data has been normalizedwith β-actin. (B) Confocal immunoﬂuorescence
sortedpopulations. Imageswere taken at 60×magniﬁcationwith scale bar equal to 10 μm.
. (D) Box plots showing signiﬁcant down-regulation of CD24 and up-regulation of CD44 in
ino-2-phenylindole.
Fig. 3. Sphere forming ability, clonogenicity, migration and invasion of the CD44highCD24low cells. (A) Representative images of spheroids originated from CD44highCD24low and
CD44lowCD24high sub-population in each cell line. (B) Plate colony formation assay for the respective population of SCC131 with number of colonies counted for 3 independent
experiments and plotted as average ± SD (C). (D) Colony morphology was found to be quite distinct in the two populations. (E) An in-vitro migration assay on the isolated fractions
of SCC131 showing representative images at 0 h and 18 h of the scratch being made. The % distance covered after the wound healing has been graphically shown (right) as a mean of
3 independent values. (F) Cells invaded from the CD44highCD24low and CD44lowCD24high cell populations of SCC084 to the lower chamber of the insert were counted. Bright ﬁeld
images of invasion assay has been shown (left) and % invasion graphically represented.
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CD44highCD24low cells and least in the CD44lowCD24high cells. Interest-
ingly, it was even relatively less in CD44highCD24high cells implying the
contribution of CD24 negativity to the migratory abilities of CD44high
cancer cells (Fig. 3E). Matrigel Invasion assay was also performed on
UPCI: SCC084 derived CD44highCD24low and CD44lowCD24high cell
populations using trans-well inserts. The number of invading cells in
CD44highCD24low was 2.5 fold higher than the CD44lowCD24high cell
type (Fig. 3F). Thus, the various cellular assays conﬁrmed the
stem-like features of CD44highCD24low cell type in comparison with
the CD44lowCD24high cell type in Oral cancer cell lines.
3.4. CD44highCD24low cells show enhanced chemo-resistance
We next investigated the chemo-resistance property of
CD44highCD24low cells. It is known that the quiescent and slow-cycling
stem cell population frequently evade drug or radiation therapy than
actively dividing cancer cells (Pattabiraman and Weinberg, 2014;
Dean et al., 2005). Towards this, we analysed the cell cycle status of
the CSC and non-CSC population of SCC25 and found remarkable differ-
ence in G0/G1, S as well as G2/M phase cells (Fig. 4A). Upon synchroni-
zation, CD44highCD24low cells appear to progress slower than the
CD44lowCD24high ones (Fig. S3A). One of the mechanisms of enhanced
chemo-resistance is their ability to pump out the excess drug with the
help of P-glycoprotein or ABCG2. We, therefore, stained the live cell
populationwith theHoechst dye at a saturated dose and then compared
the percentage of Hoechstlow cells in the CD44highCD24low and
CD44lowCD24high cells. The Hoechstlow population is referred to as
“Side Population” cells (SP phenotype) and considered as Cancer
stem-like cells in various cancers (Golebiewska et al., 2011).We indeed
observed that a higher proportion of CD44highCD24low population
retained the SP phenotype (Fig. 4B).
Next, we determined the effect of drug on these two distinct popula-
tions. Cisplatin and 5-Flourouracil are two of the most popular drug
regimens for the treatment of oral cancers (Andreadis et al., 2003).
Studies have proved that existence of CSC-like features are responsible
for the intrinsic drug resistance character in oral cancer (Valiyaveedan
et al., 2015). WST-1 assay in the presence of different concentration of
5-Flourouracil conﬁrmed that CD44highCD24low cells were signiﬁcantly
chemo-resistant than the CD44lowCD24high subpopulation in SCC25,
UPCI: SCC131 and UPCI: SCC084 cell lines (Fig. 4C and D). Besides,
5-FU treatment of the bulk cells led to the signiﬁcant enrichment of
CD44highCD24low population, suggesting survival of the resistant CSC
population (Fig. 4E). However, since the difference in percentage sur-
vival was quite low, we tried to determine IC-50 values of 5-FU treat-
ment for 72 h and found these cell lines to be inherently resistant
(Fig. S3B). But, it was noteworthy that the resistance of SCC cell lines
was directly proportional to the fraction of CD44highCD24low cells pres-
ent in its unsorted population (SCC084 N SCC25 N SCC131) (Fig. S3B).
We next, performed the similar assay with etoposide and consequently
found notable difference in viability between the CSC and the non-CSC
population of SCC131, SCC25 and SCC084 cells (Fig. 4F). Apoptotic anal-
ysis in SCC25 also showed that CD44highCD24low cells aremore resistant
to 5-FU treatment than the CD44lowCD24high cells (Fig. S4A). Overall, the
above results conﬁrm that the CD44highCD24low cells are the drug-
resistant population of the bulk tumour cells.
3.5. CD44highCD24high represents an intermediate population between CSC
and Non-CSC
We then evaluated the role of CD24 in the background of high CD44
expression, whether or how it contributes to stem-like features. We
used UPCI: SCC084 cell line to isolate the CD44highCD24high cell
type and compared them with the putative stem cell counterpart
(CD44highCD24low)(Fig. 5A). It is notable that expression of Oct4, Sox2
and C-myc was relatively higher in the CD24low population for bothUPCI: SCC131 andUPCI: SCC084 (Fig. 5B). Involucrinwasmoderately in-
creased in CD44highCD24high population suggesting the onset of differ-
entiation. As shown in Fig. 3E, migration of CD44highCD24high cell type
in SCC131 was relatively less in comparison with CD44highCD24low im-
plying CD24 in cellular motility indicative of EMT. This is further sup-
ported by inverse correlation of E-cadherin and β-catenin in CD24high
and CD24low cells (Fig. 5B). Previous studies have shown activation of
Wnt signalling pathway particularly in response to loss of E-cadherin
that lead to Cancer Stem Cell expansion and maintenance (Su et al.,
2015; Huang et al., 2015). All these data reasonably point to the fact
that CD44highCD24high cells exhibit traitswhich are transitional between
the stem-like CD44highCD24low and the non-stem CD44lowCD24high
cells.
3.6. Primary oral tumour tissues showed correlation of CSC frequency with
tumour progression
To obtain an in vivo relevance of the observationwe analysed the ex-
pression of CD44 and CD24 in primary oral tumour specimens. Previous
studies in both oral and breast cancer have associated CD44 expression
with stem cell phenotype but for CD24, expression has been quite het-
erogenous and found to bemore in differentiated areas in breast cancer
specimens (Park et al., 2010). In the present study conducted for oral
cancer, CD44 immuno-localisation was preferably membranous during
progression from normal epithelium to HNSCC, while that of CD24 was
more nuclear-oriented with slightly membrano-cytoplasmic (Fig. 6A).
Onlymembrane stainingwas considered for scoring CD44 andCD24 ex-
pression in all the samples. For the adjacent normal tissue samples, pos-
itive cells were counted only in basal/parabasal layers, as the highly
proliferative cells therein, could only develop tumour. We found high
expression of both CD44 and CD24 along the basal lining of the normal
epithelium for 80% of the patients, gradually diminishing across the
upper third layer of epithelial cells. However, with the advent of dyspla-
sia, CD24 membrane intensity moderately decreased and was almost
absent in the tumour (p b 0.001). On the other hand, CD44 staining
score was constantly high and irregularly distributed in the OSCC tu-
mour sections not varying muchwith tumour grade (Fig. 6B). Frommi-
croscopic analysis of same sections, the CD44high cells that showed low
CD24 expression were determined to calculate CD44highCD24low cell
numbers. We found its prevalence ranging from 10% in normal to 30%
in dysplasia and 47% in tumour tissues implying higher CSC frequency
with progression of the disease. Kaplan–Meier analysis did not reﬂect
any signiﬁcant co-relation between CD24low status and the overall sur-
vival (Fig. 6C). This may be due to small sample size as only 4 samples
showed high CD24 staining. In conclusion, we found patient's data to
co-relate with the cell line observation in establishing CD44highCD24low
as a putative CSC population in OSCC.
3.7. Gene expression proﬁles of OSCC derived CD44highCD24lowcells
In our attempt to probe into the CSC-speciﬁc gene signature of
CD44highCD24low cells, which may contribute to their stemness
property, we performed whole-transcriptome based proﬁling of SCC25
cell line along with CD44highCD24low and CD44lowCD24high subpopula-
tions. We observed differential expression of 474 genes with ≥1.5 fold
change between the CD44highCD24low cell and CD44lowCD24high cell
types (Supplementary File S3). Heatmap was generated using normal-
ized gene expression values for only 108 genes with ≥2 fold change
(Fig. 7A). Unsorted bulk SCC25 was more close to the non-stem cell
gene signature. Among themost up-regulated genes, there were inﬂam-
mation associated calcium binding proteins, S100A8, S100A9 whose up-
stream regulators like TNF-α, TGFβ1 and IL-8 could be involved in
tumour progression and metastasis (Supplementary File S4). These fac-
tors are known to be secreted by cancer associated stroma cells which
also stimulates angiogenesis. We indeed found changes in stem cell re-
lated genes like that of ALDH family proteins, differentiation associated
412 S. Ghuwalewala et al. / Stem Cell Research 16 (2016) 405–417genes like Keratins, KRTDAP, KLK6 together with EMT related genes
(SERPINB1, BGN, KLF9, CXCL10, JUNB, CTNNBIP1) (Tseng et al., 2009).
Others include STAT1, TIMP1, IFIT1, OAS1, FGFR3, etc. that may act aseffectors in various oncogenic signalling cascades (Dubrovska et al.,
2009). Interestingly, these genes were also discovered to be up-
regulated in 12HNSCC studies as analysed in Oncomine (Supplementary
Fig. 5.CD44highCD24low aremore stem-like than CD44highCD24high cells. (A) Representative FACS analysis inUPCI: SCC084OSCC cell line. CD44highCD24high subpopulation is ~6%, and 52.5%
in the puriﬁed CD44highCD24low and CD44highCD24high cell types. The graph shows mean of the percent of CD44highCD24high with ±SD of three independent sorting experiments.
(B) Representative western blot images of Oct-4, Nanog, Sox2, Involucrin along with E-cadherin/β-catenin in the respective cell populations.
413S. Ghuwalewala et al. / Stem Cell Research 16 (2016) 405–417File S5). Down-regulated genes, however, were few such as CLDN1,
DKK1, THBS1, CAV1, CDH2, AXL, CLDN1 etc. having diverse roles in cellu-
lar adhesion aswell asWnt signalling. Some of the genes like CDK6, SKP2Fig. 4.Drug sensitivity of CD44highCD24low andCD44lowCD24high cells. (A) CD44highCD24low and
% population in eachphase graphically represented. (B) Sortedpopulation ofUPCI: SCC131was s
SDofHoechstlow cellswere plotted for three independent experiments. Gatingwas ensuredwith
FlouroUracil (5-FU) at increasing concentrations for 72 h, followed byWST-1Cell Viability Assay
calculated. All experimentswereperformed in triplicate and data shown asmean±SD. Data in i
UPCI: SCC131 andUPCI: SCC084 cell populations at 10 μg/ml 5-FU. (E) Percentage of CD44highCD
of stem and the non-stem population in UPCI: SCC131, UPCI: SCC084 and SCC25 cell populatioetc. were involved in cell cycle. To speciﬁcally predict the possible path-
ways involved in CSC progression, the differentially expressed 474 genes
were subjected to Ingenuity Pathway Analysis. Functional Clustering ofCD44lowCD24high cell populations of SCC25were analysed for their cell cycle proﬁle and the
tainedwithHoechst dye and side population analysed byﬂowcytometry.Mean Percent±
ABCG2 inhibitor, Verapimil (50 μm). (C)MACS sorted cells fromSCC25were exposed to 5-
. Differences in Percent survival between CD44highCD24low and CD44lowCD24high cellswere
nset show statistical signiﬁcance at p b 0.001 for all concentrations. (D). Percent survival for
24low population as determined by FACS, after 5-FU treatment in SCC25 cells. (F) % Survival
ns upon etoposide treatment (25 μM).
Fig. 6. Immunohischomical analyses of primary oral tumour tissues. (A) Representative pictures showing CD44 and CD24 staining of normal oral epithelium, dysplastic epithelium and OSCC
tumour (20×magniﬁcation). Arrows represent expression of the protein. Arrowswith star represent cytoplasmic/membrane expression that was scored. Inset is of 40× and the scale bar is of
length 50 μm. (B) Box plots showing percentage of positive cells for CD24 (left) and CD44 (right), with median difference calculated by Mann–Whitney-U-Test. P value revealed signiﬁcance
only for CD24 (C) Survival curveswere plotted using KaplanMeiermethod and p-value calculated by Log Rank test (p=0.335) found to be insigniﬁcant. OSCC: Oral Squamous Cell Carcinoma.
Fig. 7.Differential mRNA expression proﬁle of CD44highCD24low and CD44lowCD24high cells of parental SCC25 line.(A) Heatmap was generated using the normalized expression values (z-
score of ΔCT) of signiﬁcant (Adjusted p ≤ 0.05, n = 2) differentially expressed genes between CD44highCD24low and CD44lowCD24high. Hierarchical clustering of different cell types have
been indicated. The scale for the heat map ranges from−1 = bright green to +1 = bright red. (B) List of Top Canonical pathways, top upstream regulators and biological functions
enriched in the gene network analysis.
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415S. Ghuwalewala et al. / Stem Cell Research 16 (2016) 405–417these genes revealed top canonical pathways and diverse molecular and
cellular functions such as Cellular growth, movement and development,
cell proliferation, cell death and survival and cell-to-cell interaction and
signalling (Fig. 7B). Taken together, these ﬁndings put together a com-
prehensive picture of CSC gene signatures in OSCC.
4. Discussion
We have done an elaborate molecular and phenotypic characteriza-
tion of the small percentage of CD24low cells within the predominantly
CD44 expressing OSCC cell lines. These cells showed relatively high ex-
pression of Sox2, Nanog, Oct4, the well-known embryonic stem cell
markers, both at the RNA and protein level. ALdh1 and Bmi1 expression
were also consistently up-regulated in CD44highCD24low cell population
of all cell lines. Aldh1, Bmi1 and Nanog have already been established as
prognostic stem cell markers in a closely related Esophageal Cancer
(Hwang et al., 2014). Their importance in OSCC is also being recognized
alongwith other cancers.Moreover, Nanog has been shown to be a ther-
apeutic target controlling CSC self-renewal in various cancers including
HNSCCs (Jeter et al., 2015). Studies in tongue carcinomas have denoted
Bmi1 as a pro-tumorigenic factor with essential role in migration and
invasion (He et al., 2015). Aldh1 activity has been found to overlap
with CD44+ population regulating common metabolic pathways in
HNSCC (Zou et al., 2012). Collectively, these speciﬁc stemness markers
were found to be enriched in the CD44highCD24low population. We
also ascertained that the descendant population derived from the con-
tinually cultured CD44highCD24low cells consisted of other cell types
whereas the non-stem population failed to generate the original sym-
metric condition within the stipulated time. This further emphasized
that CD44highCD24lowcells are indeed the CSC population in oral cancers.
CD44highCD24low cell types were found to be of mesenchymal na-
ture, as reﬂected by loss of E-cadherin and gain of Vimentin. This obser-
vation was also supported by global analysis of NCI-60 cell line
transcriptome dataset which showed expression of CD44 and CD24 to
be inversely co-related in the mesenchymal vs epitheial group of cell
lines. It might be that the over-expressed Oct4, a key determinant of
CSCs, promotes tumour-initiating properties in OSCC by mediating
EMT (Tsai et al., 2014). In this context, it must be mentioned that
CD24 expression is down-modulated by one of the known EMT factor
Twist, to enhance breast Cancer Stem Cell expansion (Vesuna et al.,
2009). In OSCC also, it may be speculated that CD24 depletion is a pre-
requisite for induction of EMT. However, in several epithelial cancers
like colorectal and nasopharyngeal, CD24+ status has been observed
as the deﬁnitive stem cell marker (Yeung et al., 2010; Yang et al.,
2014). In view of this fact, one of the studies in HNSCC has described
CD44highCD24high as the Cancer Stem Cells (Han et al., 2014).
Conversely, we have found CD44highCD24low cells to be able to form
larger spheres within a few days, indicative of its ability to undergo
asymmetric division. These were endowed with enhanced self-
renewal powers and could be perpetuated for many generations.
There are several reports implicating the role of CD24 in promoting in-
vasion and metastasis (Baumann et al., 2005). However, in our case,
CD44highCD24low cells were indeed, more migratory and invasive
under in vitro conditions. Although these cells did not proliferate any
faster, despite altered cell cycle, but under clonal conditions, could
give rise to holoclone-like colonies, a typical characteristic of stem
cells with extensive differentiation potential. On the contrary,
CD44highCD24high cells were not so enrichedwith stem-relatedmarkers.
“Side population” cells, those that effectively efﬂux out drugs, have
always been shown to have CSC property (Golebiewska et al., 2011).
In this study too, we found the presence of “SP” characteristics in the
isolated CD44highCD24low cell types. This not only exempliﬁes the
stemness characteristics of CD44highCD24low cells but also adds to the
fact that these cells contribute to intrinsic chemo-resistance and hence
difﬁcult to eliminate. It eventually becomes clearwith the sensitivity as-
says whereby CD44highCD24low cells exhibit enhanced survival upondrug treatment owing to their quiescent slow cycling state and reduced
apoptosis. Furthermore, as anticipated, the CD44highCD24low cells were
particularly enriched upon drug treatment conﬁrming that the drug
itself can select for the CSCs. CD24 has been found to be positively asso-
ciated with tumour grade in various cancers including breast cancer
where CD44+CD24− cells have already been well-characterized as
CSCs (Wei et al., 2011). Though CD24 has shown prognostic value, it ex-
erts contradictory roles particularly in response to CD44 mediated sig-
nalling (Ju et al., 2011). Moreover, in breast cancers, transitions
between CD44+CD24− and CD44+CD24+ have been evident upon
drug exposure, which seemingly contributes to CSC-like chemo-
tolerance owing to activated SFK signalling axis (Goldman et al.,
2015). Therefore, distinguishing tumourigeneic properties of these
two cell types may be difﬁcult, depending on the tumour type and
micro-environment. Although Han et al. found CD44+CD24+ to be
more tumorigenic than CD44+CD24− in cell lines derived from salivary
gland neoplasms, we found the CD44highCD24low cell type to be CSC-like
cells in cell lines primarily derived from oral cavity. Perhaps, the diverse
anatomic locations of tumour along with other etiological factors ac-
count for context-dependent role of CD markers.
Immunohistochemical studies revealed increase in the proportion of
CD44highCD24low cell type from low in normal tissues to quite high in
tumours. This is interesting as we know that Cancer Stem Cells are the
actual tumour initiating subpopulation and can expand depending on
its evolutionary landscape during cancer development (Kreso and
Dick, 2014). A number of studies have shown existence of CSCs in
most of the histo-pathologically advanced tumours with lymph node
metastasis. Under normal conditions, both CD44 and CD24 are involved
in normal differentiation process, which is disrupted upon loss of CD24,
and epithelial integrity is lost leading to tumorigenesis (Abdulmajeed
et al., 2013) Despite this step by step procedure of tumour formation,
extensive heterogeneity does exist from one individual to another
(Park et al., 2010). Neither all the patients show similar CSC hierarchy
nor do they respond to CSC-targeted treatments in a similar manner.
To derive speciﬁc gene signatures of CSCs in OSCC, we performed
microarray based gene expression analysis of the various sub-
populations of SCC25 cell line. Differential gene expression analyses be-
tween the CD44highCD24low and CD44lowCD24high cell types implicated
a number of genes in stemness, differentiation and EMT. We know
that these features are generally high in cells at the tumour edges
where it comes in contact with the stroma. Sometimes the cancer cells
themselves take up the tasks of cancer associated ﬁbroblasts via epithe-
lial plasticity or vice-versa (Kinugasa et al., 2014). This is notable in our
results as most of the genes up-regulated in CD44highCD24low cells have
important roles in tumour-microenvironment. Inﬂammation at the tu-
mour-stroma interface produces those ECM degrading enzymes con-
tributing to invasion, metastasis and angio-genesis. A very interesting
fact is that the CD markers used for conventional CSC identiﬁcation
are in reality determinants of autocrine/paracrine signalling whereby
receptor-ligand interaction plays essential roles in stemness. Interaction
with interleukins (IL-8) or chemokines (CXCL10, CXCL14) has impor-
tant implications in the role of these CD receptors (van der Horst
et al., 2012). In addition, stromal derived IFNs, TNF or TGF-β leads to
selection of stress-resistant CSCs with constitutive Stat1 activation
(Khodarev et al., 2012). Moreover, Claudinlow phenotype has been
found to be linked with EMT and tumour initiation in breast cancers
with TGF-β participation (Dave et al., 2012). Another secretory factor,
Thrombospondin-1 inhibits self-renewal via its interaction with CD47
on endothelial cells (Kaur et al., 2013). From the literature survey, we
thus put forward that several genes identiﬁed in themicroarray analysis
were indeed signiﬁcantly associated with CSC features.
5. Conclusion
In conclusion, the CD44highCD24low cell population from oral cancer
cell lines was notably distinct from other populations. They not only
416 S. Ghuwalewala et al. / Stem Cell Research 16 (2016) 405–417displayed increased CSC and EMT properties but also enhanced in-vitro
tumorigenic potential. Drug resistance, invasion and metastasis ability
of these cell types were evident and could be partially explained by
their gene expression proﬁle. Correlation with patient sample was also
manifested. Taken together, these cells certainly exhibit CSC phenotype
and thus can be targeted for better treatment of the disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.02.028.
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